Bernard Lenormand

2.2k total citations
52 papers, 1.6k citations indexed

About

Bernard Lenormand is a scholar working on Hematology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Bernard Lenormand has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 19 papers in Pathology and Forensic Medicine and 16 papers in Immunology. Recurrent topics in Bernard Lenormand's work include Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Immune Cell Function and Interaction (9 papers). Bernard Lenormand is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Immune Cell Function and Interaction (9 papers). Bernard Lenormand collaborates with scholars based in France, Canada and United States. Bernard Lenormand's co-authors include Hervé Tilly, Christian Bastard, M. Monconduit, A Kunlin, C. Bigorgne, Aspasia Stamatoullas, H Piguet, Annick Rossi, Dominique Boulet and Marc Vasse and has published in prestigious journals such as Blood, The American Journal of Surgical Pathology and British Journal of Haematology.

In The Last Decade

Bernard Lenormand

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Lenormand France 20 949 638 512 355 336 52 1.6k
P. M. Kluin Netherlands 21 1.0k 1.1× 431 0.7× 797 1.6× 260 0.7× 314 0.9× 40 1.8k
András Matolcsy Hungary 24 988 1.0× 699 1.1× 583 1.1× 337 0.9× 381 1.1× 106 1.9k
Mireia Camós Spain 22 661 0.7× 500 0.8× 547 1.1× 576 1.6× 329 1.0× 57 1.8k
Kaaren K. Reichard United States 22 576 0.6× 611 1.0× 413 0.8× 515 1.5× 452 1.3× 116 1.7k
Ana Balanzategui Spain 25 539 0.6× 492 0.8× 459 0.9× 491 1.4× 427 1.3× 70 1.5k
Benet Nomdedeu Spain 22 592 0.6× 829 1.3× 349 0.7× 881 2.5× 285 0.8× 88 1.8k
Jeanette Lundin Sweden 21 1.1k 1.2× 1.1k 1.7× 544 1.1× 448 1.3× 1.1k 3.1× 53 2.2k
Georg Hopfinger Austria 22 987 1.0× 984 1.5× 533 1.0× 390 1.1× 458 1.4× 58 1.8k
Domenico Novero Italy 25 809 0.9× 408 0.6× 570 1.1× 164 0.5× 354 1.1× 82 1.7k
Piero Galieni Italy 26 700 0.7× 564 0.9× 706 1.4× 739 2.1× 275 0.8× 89 1.7k

Countries citing papers authored by Bernard Lenormand

Since Specialization
Citations

This map shows the geographic impact of Bernard Lenormand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Lenormand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Lenormand more than expected).

Fields of papers citing papers by Bernard Lenormand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Lenormand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Lenormand. The network helps show where Bernard Lenormand may publish in the future.

Co-authorship network of co-authors of Bernard Lenormand

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Lenormand. A scholar is included among the top collaborators of Bernard Lenormand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Lenormand. Bernard Lenormand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dreden, Patrick Van, Barry Woodhams, Bernard Lenormand, & Marc Vasse. (2011). Haemostasis Change in Intensive Care Patients with Severe Sepsis and Patients with Organ Failure without Sepsis. Blood. 118(21). 1233–1233. 2 indexed citations
2.
Lenormand, Bernard, et al.. (2010). The new haematology analyzer DxH 800: an evaluation of the analytical performances and leucocyte flags, comparison with the LH 755. International Journal of Laboratory Hematology. 33(2). 138–145. 30 indexed citations
3.
4.
Cordel, N., et al.. (2004). Étude de la clonalité des lymphocytes cutanés et sanguins au cours du syndrome d’hypersensibilité médicamenteuse chez 6 malades. Annales de Dermatologie et de Vénéréologie. 131(12). 1059–1061. 6 indexed citations
5.
Lesesve, Jean‐François, Bernard Lenormand, & J. P. Vannier. (2002). Increase of high fluorescence reticulocytes indicates mobilization of peripheral stem cells in children recovering from aplasia after chemotherapy or bone marrow transplantation. Clinical & Laboratory Haematology. 24(5). 291–294. 2 indexed citations
6.
Dubus, Pierre, M. Beylot‐Barry, Philippe Courville, et al.. (2002). Value of Interphase FISH for the Diagnosis of t(11;14)(q13;q32) on Skin Lesions of Mantle Cell Lymphoma. American Journal of Clinical Pathology. 118(6). 832–841. 17 indexed citations
7.
Stamatoullas, Aspasia, Gérard Buchonnet, Stéphane Leprêtre, et al.. (2000). De novo acute B cell leukemia/lymphoma with t(14;18). Leukemia. 14(11). 1960–1966. 34 indexed citations
8.
Bouloc, Anne, Marie‐Hélène Delfau‐Larue, Bernard Lenormand, et al.. (1999). Polymerase Chain Reaction Analysis of Immunoglobulin Gene Rearrangement in Cutaneous Lymphoid Hyperplasias. Archives of Dermatology. 135(2). 168–72. 45 indexed citations
9.
10.
Lesesve, Jean‐François, Pascale Schneider, Christian Bastard, et al.. (1997). Therapy-related acute myeloid leukemia with t(8;21) in a child with previous Ewing's sarcoma. Medical and Pediatric Oncology. 29(2). 132–134. 9 indexed citations
11.
François, Arnaud, Jean‐François Lesesve, Aspasia Stamatoullas, et al.. (1997). Hepatosplenic Gamma/Delta T-Cell Lymphoma: A Report of Two Cases in Immunocompromised Patients, Associated with Isochromosome 7q. The American Journal of Surgical Pathology. 21(7). 781–790. 53 indexed citations
12.
Fruchart, Christophe, Bernard Lenormand, Christian Bastard, et al.. (1996). Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia. American Journal of Hematology. 53(3). 175–180. 15 indexed citations
13.
Lenormand, Bernard, et al.. (1995). Synergism of interleukin‐12 and interleukin‐3 on development of hematopoietic progenitors. European Journal Of Haematology. 54(3). 172–175. 11 indexed citations
14.
15.
Lenormand, Bernard, M Bizet, Christophe Fruchart, et al.. (1994). Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic value.. PubMed. 8(6). 1019–26. 22 indexed citations
16.
Lenormand, Bernard, et al.. (1994). Sensitivity of myeloid progenitors to NK‐cell depletion. American Journal of Hematology. 47(4). 290–294. 4 indexed citations
17.
Voisin, Sophie, et al.. (1993). Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies.. PubMed. 7(2). 161–7. 32 indexed citations
18.
Solary, Éric, et al.. (1992). Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).. PubMed. 6(5). 393–9. 93 indexed citations
19.
Lenormand, Bernard, et al.. (1992). Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapy. American Journal of Hematology. 39(3). 172–175. 12 indexed citations
20.
Lenormand, Bernard, N. Ghanem, Hervé Tilly, et al.. (1991). Rearrangements of immunoglobulin light and heavy chain genes and correlation with phenotypic markers in B-cell chronic lymphocytic leukemia.. PubMed. 5(11). 928–36. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. M. Kluin Breakdown of academic impact, for papers by András Matolcsy Breakdown of academic impact, for papers by Mireia Camós Breakdown of academic impact, for papers by Kaaren K. Reichard Breakdown of academic impact, for papers by Ana Balanzategui Breakdown of academic impact, for papers by Benet Nomdedeu Breakdown of academic impact, for papers by Jeanette Lundin Breakdown of academic impact, for papers by Georg Hopfinger Breakdown of academic impact, for papers by Domenico Novero Breakdown of academic impact, for papers by Piero Galieni
Rankless by CCL
2026